To better uncover the relationship between EZH2 and p65 in the progression of human glioma, we further examined EZH2 and p65 expression in human glioma samples (n=180) by immunohistochemical (IHC) staining (Fig. 6a, b). Here, EZH2 is linked to central nervous system cancer.